KZA 0.00% 8.0¢ kazia therapeutics limited

"We now know we have a drug candidate that could go head-to-head...

  1. 47 Posts.
    "We now know we have a drug candidate that could go head-to-head with the most commonly-used cytotoxics in chemotherapy, but with the huge advantage of being highly on-target with no apparent toxicity."

    I've read it five or six times now. Slowly. O.M.G.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.